Volume 1

  • No. 12 December 2022

    Cardiovascular risks after COVID-19 disease versus vaccine

    Kwan et al. show that the risk of postural orthostatic tachycardia syndrome (POTS) is increased after COVID-19 vaccination but still more than five times lower than after surviving COVID-19 disease.

    See Kwan et al.

  • No. 11 November 2022

    Fight-or-flight response revisited

    Using genetically altered mice, Papa et al. find that phosphorylation of Rad and augmented calcium influx are essential for cardiac fight-or-flight responses.

    See Papa et al.

  • No. 10 October 2022

    Ventricular arrhythmia after cardiac infarction

    By combining prospective clinical and mechanistic computational studies, Sung et al. show that the fat that infiltrates the post-myocardial infarction scar is a dominant factor in eliciting infarct-related ventricular arrhythmia.

    See Sung et al.

  • No. 9 September 2022

    The ‘sunset years’ come with sex differences in cardiometabolic health

    Using a large cohort of people that spans three generations, Zhernakova et al. find that sex differences in risk factors and biomarkers for cardiometabolic diseases change dynamically with age.

    See Zhernakova et al. and News & Views by Miller and Heather

  • No. 8 August 2022

    Collateral arteries of the heart

    The figure adapted from Anbazhakan et al. represents imaging (black and white), hemodynamic forces (magenta), and collateral artery tracing (cyan) in a cohesive collage. The use of a collage symbolizes the interdisciplinary nature of this work.

    See Anbazhakan et al. and News & Views by Mayerich and Wythe

  • No. 7 July 2022

    Leukocytes and cardiac electrical storm

    The cover image features original ECG traces from the STORM mice, in which ventricular tachycardia occurs owing to hypokalemia and acute myocardial infarction. Using this new model of non-genetic, spontaneous arrhythmia, Grune et al. show that leukocytes regulate the arrhythmia burden, and that immune cell dysfunction elicits an electrical storm and sudden cardiac death.

    See Grune et al. and News & Views by Nicolás-Ávila and Hidalgo

  • No. 6 June 2022

    Old drug, new tricks

    Thalidomide treatment of individuals with severely symptomatic arteriovenous malformations who are refractory to conventional therapies holds promise, shows study by Boon et al.

    See Boon et al.and News & Views by Teng and Siegel

  • No. 5 May 2022

    Intestinal endothelium and stem cell cross-talk

    Stem cells (green) and blood vessels (red) in early stage mouse intestinal adenoma.

    See Bernier-Latmani et al. and News & Views by Koh

  • No. 4 April 2022

    Deep learning predicts survival after ischemic heart disease

    Popescu et al. develop a deep learning approach that combines neural networks and survival analysis from cardiac magnetic resonance images and clinical covariates for patients with ischemic heart disease to predict arrhythmic sudden death.

    See Popescu et al. and News & Views by Krittanawong

  • No. 3 March 2022

    The Lands and Seas of the Planet Heart

    Koenig et al. present a comprehensive cellular atlas of healthy and failing human hearts, based on single-cell and single-nucleus RNA sequencing of cardiac biopsies from 45 individuals.

    See Koenig et al.

  • No. 2 February 2022

    Hundreds of new mouse genes functionally linked to CVD

    Spielmann et al. screen the cardiac function and structure of about 4,000 monogenic knockout mice to identify 486 new genes whose lack results in cardiac disease, and validate a number of these genes in humans via UK Biobank human data.

    See Spielmann et al. and News & Views by Ahlberg and Olesen

  • No. 1 January 2022

    Reaching out

    The cover image of our first issue is a wool artwork entitled ‘Reach’, created by contemporary British artist Sarah Vaci. Reflecting the originality and courage of the artwork, Nature Cardiovascular Research aims to bring together the cardiovascular and blood community, and promote, champion and disseminate inspiring, thought-provoking and original research.